ArticleCancer discovery2021

TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors.

Emiliano Cocco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.